Dyadic International Inc. (NASDAQ: DYAI), a biotechnology company specializing in large-scale protein manufacturing for vaccines, therapeutics, and non-pharmaceutical applications like biofuels and next-generation foods, (read entire press release) reached a new 52-week high of $2.42 on Thursday, May 30, 2024. This achievement marks a significant 103% increase from its 52-week low of $1.19. The stock's 50-day moving average stands at $1.6631, while the 200-day moving average is $1.6521, culminating in a "Golden Cross" on May 30, 2024. Furthermore, the stock demonstrated a "Jack in the Box" pattern with a Bullish Swing Set-Up on Friday, May 31, 2024. Read the full press release for more details.
As the bird flu outbreak looms, with a third person now infected, the U.S. government has initiated discussions with Moderna (NASDAQ: MRNA) regarding an avian flu vaccine. Other companies, including Pfizer (NYSE: PFE), Novavax (NASDAQ: NVAX), BioNTech (NASDAQ: BNTX), and Dyadic International Inc. (NASDAQ: DYAI), are also potential collaborators. For Dyadic’s latest developments in more detail, read more now!
Dyadic International Inc. (NASDAQ: DYAI) was recently featured with other MEME stocks trending now: GameStop (NYSE: GME). AMC Entertainment (NYSE: AMC), Novavax Inc. (NASDAQ: NVAX), Peraso Inc. (NASDAQ: PRSO), among others, Read more.
Dyadic International's COO, Joe Hazelton, recently discussed the bird flu threat, the company's expansion into next-generation foods, and the "Food vs Fuel" debate on "The Street Reports Podcast," Listen Now! Furthermore, the company said that the management will attend key industry events in June 2024. These events include BIO 2024 San Diego, CA, from June 3–6, with a presentation on June 5 at 11:00 AM PT; Future Food Tech-Alt Proteins at the Chicago, IL, from June 17–18; and the 2024 NIIMBL National Meeting in, Washington, DC, from June 25–27.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com
